ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) is one of the best drug stocks to buy according to analysts. ANI Pharmaceuticals, Inc ...

The pharma royalty funding market hit a record $10 billion in 2025. A single AI experiment that improved a cancer drug in ...

The large AI player is paying $400 million for the tiny startup, signaling a potential shift in how tech is approaching ...

Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635), a leading global pharmaceutical, health and wellness company, today announced its standalone ...

Transaction Positions XTL at the Forefront of the Rapidly Expanding Global Psychedelic Therapeutics Market Following Major U.S. Regulatory ...

The new plant will give Novartis end-to-end capabilities centered on North Carolina, where it plans to have five facilities ...

Amgen has launched a late-stage program to test the feasibility of switching patients from weekly GLP-1 injections to its own ...

In a report released today, Danielle Brill from Truist Financial maintained a Buy rating on BridgeBio Pharma, with a price target of $102.00.

TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today ...

A UK biotech company has launched what it describes as a world‑first platform of lab‑grown human muscle designed to give drug ...

China-US biotech Brii Bio (HKEX: 2137) has reported data suggesting sustained control of hepatitis B virus after treatment ...